Hemophilia Federation of America: Assisting and Advocating for the Bleeding Disorders Community

Health News

Safe Summertime

Print This Post Print This Post Posted on: July 4th, 2010 by RSS | Leave a comment

Go Outside and Enjoy the Season Safely ~ It’s summertime, and that means it’s time to go outside and enjoy the weather.

FIFA World Cup 2010

Print This Post Print This Post Posted on: June 12th, 2010 by RSS | Leave a comment

Tips for Travel to South Africa ~ Several cities in South Africa will host the 2010 FIFA World Cup June 11 through July 11. During these exciting weeks, don’t get sent to the sidelines with an illness or injury. Follow these tips to safeguard your he…

American Plasma Users Coalition, A-PLUS, Seeks FDA-Community Research Agenda to Enhance The Safety of Our Nation’s Blood Supply

Print This Post Print This Post Posted on: June 9th, 2010 by sswindle | Leave a comment

The Department of Health and Human Services, Advisory Committee on Blood Safety and Availability will be reviewing the current Food and Drug Administration (FDA) policy recommending that men wh have sex with another man (MSM) even one time since 1977 should be deferred indefinitely from donating blood. Click here

Joint Statement on Addressing the MSM Blood Ban by Groups Representing People Living with Hemophilia, Gay Men and People Living with HIV/AIDS

Print This Post Print This Post Posted on: June 9th, 2010 by sswindle | Leave a comment

The Department of  Health & Human Services, Advisory Committee on Blood Safety and Availability will be reviewing the current Food and Drug Administration (FDA) policy recommending that men who have sex with another man (MSM) even one time since 1977 should be deferred indefinitely from donating blood.  Click here for

Deadly blood colors debate

Print This Post Print This Post Posted on: April 5th, 2010 by sswindle | Leave a comment

By Andrew Zajac

April 4, 2010

A woman who watched her husband die of AIDS after receiving a tainted donation and who now has the disease herself is torn over gay rights versus blood supply safety.

Reporting from Washington – As a liberal-minded person, Kathy …

Potential Risk to Blood Supply Probed

Print This Post Print This Post Posted on: April 5th, 2010 by sswindle | Leave a comment

APRIL 4, 2010, 10:27 P.M. ET

XMRV Virus Gets Attention of Health Officials, but It’s Unclear if There Is Any Danger

An infectious virus linked to two diseases is drawing the attention of public-health officials, who are investigating the potential threat to the nation’s blood supply.

It isn’t clear if the virus, known …

Infusion Set Needles [Manufactured by Nipro for Exelint]: Recall

Print This Post Print This Post Posted on: January 26th, 2010 by sswindle | Leave a comment

Exel/Exelint Huber needles,
Exel/Exelint Huber Infusion Sets
Exel/Exelint “Securetouch+” Safety Huber Infusion Sets

Audience: Hospital Risk Managers, Surgical Service personnel

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets and Exel/Exelint “Securetouch+” Safety Huber Infusion Sets, manufactured by Nipro …

Mortality Data now Available from VitalStats

Print This Post Print This Post Posted on: January 15th, 2010 by RSS | Leave a comment

Seven prebuilt tables of 2005 mortality data are now available. Data presented in these tables include the number of U.S. resident deaths in 2005 by cause of death, age, race, sex, Hispanic origin, and geographic area. Tables with comparable data for…

Posted: 11/6/2009

Print This Post Print This Post Posted on: November 6th, 2009 by sswindle | Leave a comment

Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion (PDF – 68KB)

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

Print This Post Print This Post Posted on: November 2nd, 2009 by sswindle | Leave a comment

26. October 2009 08:42

PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB). Hemophilia is a rare and debilitating genetic …